Cargando…
Suppression of Immunodominant Antitumor and Antiviral CD8(+) T Cell Responses by Indoleamine 2,3-Dioxygenase
Indoleamine 2,3-dioxygenase (IDO) is a tryptophan-degrading enzyme known to suppress antitumor CD8(+) T cells (T(CD8)). The role of IDO in regulation of antiviral T(CD8) responses is far less clear. In addition, whether IDO controls both immunodominant and subdominant T(CD8) is not fully understood....
Autores principales: | Rytelewski, Mateusz, Meilleur, Courtney E., Atef Yekta, Maryam, Szabo, Peter A., Garg, Nitan, Schell, Todd D., Jevnikar, Anthony M., Sharif, Shayan, Singh, Bhagirath, Haeryfar, S. M. Mansour |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938761/ https://www.ncbi.nlm.nih.gov/pubmed/24587363 http://dx.doi.org/10.1371/journal.pone.0090439 |
Ejemplares similares
-
Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, gamma radiation, and cisplatin
por: Vareki, Saman Maleki, et al.
Publicado: (2014) -
Neutrophils are Essential in Short Hairpin RNA of Indoleamine 2,3- Dioxygenase Mediated-antitumor Efficiency
por: Liu, Kuan-Ting, et al.
Publicado: (2016) -
Localization of Indoleamine 2,3-Dioxygenase-1 and Indoleamine 2,3-Dioxygenase-2 at the Human Maternal-Fetal Interface
por: Kudo, Yoshiki, et al.
Publicado: (2020) -
The Role of Indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy
por: Hornyák, Lilla, et al.
Publicado: (2018) -
Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy
por: Brochez, Lieve, et al.
Publicado: (2021)